http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1228549-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90
filingDate 1983-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c03c4a93dc0cd824a11a8e5d7ad6047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e63682f07c6e5385283f12b5e907622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cfedeb78d4ff96319c6dba9b26319f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0151180f51b0a046c97d9a8a9675e155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9822c817a114eda1809d6d890b8cca3c
publicationDate 1987-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1228549-A
titleOfInvention Use of 1,4-dihydropyridines in antiarteriosclerotic agents and their preparation
abstract Use of 1,4-dihydropyridines in antiarteriosclerotic agents and their preparation ABSTRACT OF THE DISCLOSURE A method of countering arteriosclerosis in a patient comprising administering to such patient an anti-arteriosclerotic effective amount of a 1,4-dihydropyridine of the formula in which R1 and R2 each independently is alkyl or alkoxyalkyl having up to 12 C atoms, the alkyl radical optionally being substituted by fluorine or chlorine, and R3 is one or two substituents independently selected from the group comprising nitro, trifluoromethyl, halogen and cyano. The material is effective even upon oral administration.
priorityDate 1982-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11984615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70695641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4507
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426356519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID292385
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID292385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16722120

Total number of triples: 45.